Crossmark

Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial

Crossref DOI link: https://doi.org/10.1186/s12876-017-0572-2

Published Online: 2017-01-19

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

An, Jihyun

Lim, Young-Suk

Kim, Gi-Ae

Han, Seong-bong

Jeong, Wonhee

Lee, Danbi

Shim, Ju Hyun

Lee, Han Chu

Lee, Yung Sang
Funding

Funding for this research was provided by:

Novartis

Korean National Health Clinical Research (NHCR) Project, Ministry of Health and Welfare (HC15C3380)

Korean Health Technology R and D Project, Ministry of Health and Welfare (HI14C1061)

Proteogenomic Research Program through the National Research Foundation of Korea funded by the Korea government